×

Warning

JUser: :_load: Unable to load user with ID: 109

Treatment with the cyclin dependent kinase (CDK) 4/6 inhibitor palbociclib achieves a clinically meaningful improvement in overall survival in patients with hormone receptor positive (HR+) human epidermal growth factor receptor-2 negative (HER2-) advanced breast cancer that has relapsed or progressed on hormonal therapy, according to the final analysis of overall survival results from the PALOMA-3 study reported at ESMO 2018 (1).

Read more ...

Most parents know that the diet and exercise habits of a pregnant woman impacts the health of her baby, but little is known about how a father’s health choices are passed to his children. A new study by researchers at The Ohio State University Wexner Medical Center finds that lifestyle practices of fathers prior to conception may have a major impact on the lifelong health of their children.

Read more ...

More Articles ...

Subcategories